Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2012-02-24 20:29:46
Reporting Period:
Filing Date:
Accepted Time:
2012-02-24 20:29:46
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
69499 Mylan Inc. MYL Pharmaceutical Preparations (2834) 251211621
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1113186 J Douglas Leech 1500 Corporate Drive
Canonsburg PA 15317
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-23 16,875 $14.12 48,027 No 4 M Direct
Common Stock Disposition 2012-02-23 16,875 $23.36 31,152 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Right to Buy Acquisiton 2012-02-23 16,875 $0.00 16,875 $14.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,875 2003-06-20 2012-06-20 No 4 M Direct
  1. As disclosed in the Company's Form 10-Q for the quarter ended September 30, 2011, Ms. Leech's stock options were among those held by directors that were set to expire in 2012.